Shore View Nursing & Rehabilitation Center | |
2865 Brighton 3rd Street, Brooklyn, New York 11235 | |
(718) 891-4400 | |
Name | Shore View Nursing & Rehabilitation Center |
---|---|
Location | 2865 Brighton 3rd Street, Brooklyn, New York |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 320 |
Occupancy Rate | 79.97% |
Medicare ID (CCN) | 335288 |
Legal Business Name | Shore View Acquisition I Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1336134915 |
Organization Name | H A SCHACHTER ERNEST DICKER ETAL SHORE VIEW NURSING HOME |
Address | 2865 Brighton 3rd St, Brooklyn, NY 11235 |
Phone Number | 718-891-4400 |
News Archive
While eating less and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.
The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older.
Researchers with the University of Pennsylvania School of Veterinary Medicine have demonstrated the process by which the cancer-causing chemical dioxin attacks the cellular machinery, disrupts normal cellular function and ultimately promotes tumor progression.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.
› Verified 1 days ago
NPI Number | 1336553080 |
Organization Name | SHORE VIEW ACQUISITION I, LLC |
Doing Business As | SHORE VIEW NURSING AND REHABILITATION CENTER |
Address | 2865 Brighton 3rd St, Brooklyn, NY 11235 |
Phone Number | 718-891-4400 |
News Archive
While eating less and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.
The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older.
Researchers with the University of Pennsylvania School of Veterinary Medicine have demonstrated the process by which the cancer-causing chemical dioxin attacks the cellular machinery, disrupts normal cellular function and ultimately promotes tumor progression.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
While eating less and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.
The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older.
Researchers with the University of Pennsylvania School of Veterinary Medicine have demonstrated the process by which the cancer-causing chemical dioxin attacks the cellular machinery, disrupts normal cellular function and ultimately promotes tumor progression.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 15.49 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.34 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 62.55 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.38 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.26 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 6.93 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.01 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 6.77 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.39 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.02 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 13.4 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.78 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.48 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.96 | 95.98 |
Percentage of short-stay residents who made improvements in function | 78.01 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.44 | 82.93 |
News Archive
While eating less and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.
The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) for the chronic management of some urea cycle disorders (UCDs) in patients ages 2 years and older.
Researchers with the University of Pennsylvania School of Veterinary Medicine have demonstrated the process by which the cancer-causing chemical dioxin attacks the cellular machinery, disrupts normal cellular function and ultimately promotes tumor progression.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.
› Verified 1 days ago
Brooklyn Gardens Nursing & Rehabilitation Center Location: 835 Herkimer Street, Brooklyn, New York 11233 Phone: (718) 221-2600 | |
The Heritage Rehabilitation And Health Care Center Location: 5606 15th Ave, Brooklyn, New York 11219 Phone: (718) 851-1000 | |
Spring Creek Rehabilitation & Nursing Care Center Location: 660 Louisiana Ave, Brooklyn, New York 11239 Phone: (718) 669-7100 | |
New Carlton Rehab And Nursing Center, L L C Location: 405 Carlton Ave, Brooklyn, New York 11238 Phone: (718) 789-6262 | |
Cobble Hill Health Center Inc Location: 380 Henry Street, Brooklyn, New York 11201 Phone: (718) 855-6789 |